Roivant Sciences Ltd. (ROIV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 19.22B |
| Enterprise Value | 17.9B |
| P/E Ratio | -69.44 |
| PEG Ratio | 0.83 |
| Price/Sales Ratio | 2,721.21 |
| Price/Book Ratio | 4.85 |
| Enterprise/Revenue | 2,561.93 |
| Enterprise/EBITDA | -81.01 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -36.29 |
| Operating Margin | -155.61 |
| Return On Assets | -0.05 |
| Return On Equity | -0.07 |
| Revenue | 8.26M |
| Revenue/Share | 0.01 |
| Gross Profit | 6.98M |
| EBITDA | -261.23M |
| Net Income | -299.77M |
| Diluted EPS | -0.43 |
| Total Cash | 4.3B |
| Total Cash/Share | 6.12 |
| Total Debt | 107.44M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 18.37 |
| Book Value Per Share | 7.54 |
| 52-Week Change | 171.74 |
| 52-Week High | 32.79 |
| 52-Week Low | 10.71 |
| Moving Average 50 Days | 29.19 |
| Moving Average 200 Days | 23.65 |
| Average Volume | 5.52M |
| Shares Outstanding | 719.27M |
| % Held by Institutions | 76.08 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |